Revivelife Clinic I Naturopath in Ottawa



The NMR LipoProfile® cardio test uses nuclear magnetic resonance (NMR) spectroscopy to directly measure advanced cardio (including the number of LCL particles and sizes, and HDL particles) and inflammation markers. The test also provides a standard cholesterol test and a calculation of one's risk of type 2 diabetes by assessing abnormalities in lipoprotein markers that are closely associated with insulin resistance (a precursor to type 2 diabetes). Includes the Lipid Panel: Cholesterol, HDL-C, TG, LDL-C, CHOL/HDL-C Ratio and Advanced Markers: NMRP (LDL particles, HDL particles) ApoA1, ApoB, Lp(a), A/B ratio, Homocysteine,

Key for a comprehensive overview of your cardiovascular status, especially if you have a strong family history or are in perimenopause or andropause where hormones shift and your risk factors may increase.


This signature DNA Genetic Test Health & Hormones assess over 100 genes for Detoxification Pathways, Health Overall, Hormone Metabolism, Nutrition, Alcohol Tolerance, Vitamin & Minerals needs, Blood Sugar, Weight & Metabolism, Cardiovascular Health, Fitness (Exercise Performance & Impact) & Injury Risk.
Best suited to those who want the most comprehensive approach to DNA health.


A heat sensitive “snap-shot” picture of the body or regions of the body to compliment traditional medical testing to aid in the early detection of disease or internal dysfunction. Thermography is a painless, non-invasive, state of the art clinical test, using an infrared camera to measure heat patterns and blood flow in body tissues without any exposure to radiation.

May be recommended to assess breast, thyroid, uterus, circulatory, or inflammatory concerns. Testing includes a Naturopathic consult

Test Options
Regional & Consult (Breast/Prostate)
Wellness & Consult (Breast, Thyroid & Uterus)
Full Body & Consult (Body)


Evaluation of overall health including inflammation, cardiovascular status, select nutrients and hormones with targets of optimal vs normal range. Add on options for athletic performance, micronutrients, amino acids, and or essential fatty acids available.

May be recommended if you are experiencing fatigue, insomnia, anxiety, depression, hormone changes or for longevity medicine.


This DNA Genetic Test Skin focuses on those genes associated with custom formulating an optimal beauty regime for your skin. It includes looking at nutrients for skin health, elasticity and collagen formation.

Best suited to those who want to achieve the most from their skin care products and beauty routine.

previous arrow
next arrow
+Why do longevity and anti-aging testing? The ability to take a snap-shot of the body allows us to work proactively towards optimal wellness vs reactively to disease.
+Do I need a referral from my health care provider? No, you do not need a referral to have these tests done. Simply book an appointment.
+What are the common symptoms & conditions associated with the aging process? The symptoms and conditions associated with the aging process may include:
  • Fatigue
  • Brain: reduced memory and cognition, dementia, Alzheimer’s disease
  • Mood: anxiety, depression, stress, insomnia
  • Thyroid: fatigue or hyper energy, cold body temperature, hoarse voice, changes in weight
  • Immune: allergies, intolerances, autoimmune conditions, frequent colds, flu, and risks associated
  • Digestion: low HCL, reduced enzymes, weaker digestion
  • Cardiovascular: atherosclerosis, high blood pressure, high cholesterol
  • Metabolic: weight gain, diabetes
  • Nutrients: deficiencies, malnutrition, malabsorption
  • Hormone Imbalance: fibrocystic breasts, mood changes, PMS, PCOS, perimenopause/menopause, andropause, thinning or brittle hair, excess sweating, body temperature changes, water retention, change in appetite, infertility, low libido
  • Pain: rheumatoid arthritis, osteoarthritis, headaches, joint pain, muscular stiffness, and generalized pain, reduced mobility 
+What are the risks of aging more rapidly? The principal risks of aging more rapidly include:
  • Genetic Link
  • Poor Diet – standard American diet, which is low in fiber and high in sugar and saturated fats
  • Excess Alcohol
  • Lack of Nutrients – reduced intake, lower quantities in the food supply, weaker digestion, lack of absorption
  • Food Hypersensitivities – Intolerances, Sensitivities IgG and or Allergies IgE
  • Digestive Imbalance – Low Stomach Acid, SIBO, Leaky Bowel, Colitis, Chron’s, IBS, Celiac
  • Inflammation
  • Injury
  • Lack of Exercise
  • Stress
  • Medication Use – antibiotics, NSAIDs, BCP
+How do I know which longevity test is right for me?  Your Naturopath or Nurse Practitioner will help assess which test is right for you, including an analysis of the most cost efficient path of testing. We recommend a New Patient Visit with one of our Naturopathic Doctors for the most comprehensive approach to your health or a Pre-Lab Visit for a quick snapshot prior to lab testing as there are many tests available.  Lab testing alone is a one-dimensional picture of your health. The expertise of a health professional is required to create a three-dimensional picture for proper selection, and interpretation of lab testing. To complete your care we recommend booking your Post-Lab consult 2 weeks after testing to review your results and receive your tailored health plan.
+How are these tests different than the test I get at my medical doctor’s office? Your medical doctor focuses on tests covered under OHIP. The tests offered here include tests that are not offered at medical doctor’s offices in Ontario. In addition, an  in-depth review of your lifestyle, health, and other aspects of what defines your optimal levels are taken into consideration.
+Are these tests covered under insurance plans? Third-party insurance companies may cover all or a portion of your consultations. Most of the other integrative testing is not currently covered by private insurance companies. Please check with your individual provider for details and how to submit claims.
+How is longevity support approached? The use of anti-inflammatory menus, targeted antioxidants, select vitamins or minerals, natural or bio-identical hormone support, acupuncture or other integrative therapies is often advised  1-47.  Additional testing including hormones, digestion, and Organic Acid Test (a test that assesses digestion, detox pathways, select nutrients, and neurotransmitters) may be considered to further investigate your health and anti-aging strategies. Referral for mammograms, ultrasounds, or other traditional medical testing is recommended where applicable.
We recommend a New Patient Visit for the most comprehensive approach to your health or a Pre-Lab Visit for a quick snapshot before lab testing and a Post-Lab consult which is included in the thermography testing to review your results and receive your tailored health plan. To book an appointment Click Here!


  1. Aging slowed in mice with supplement mix, Retrieved 3,16,20
  2. Samaras N, Papadopoulou M-A, Samaras, D, et al, Off-label use of hormones as an antiaging strategy: a review, Clin Interv Aging. 2014; 9: 1175-1186.
  3. Zouboulis CC, Makrantonaki E. Hormonal therapy of intrinsic aging. Rejuvenation Res. 2012;15:302–312.
  4. Samaras N, Samaras D, Frangos E, Forster A, Philippe J. A review of age-related dehydroepiandrosterone decline and its association with well-known geriatric syndromes: is treatment beneficial? Rejuvenation Res. 2013;16(4):285–294.
  5. Samaras N, Samaras D, Lang PO, et al. A view of geriatrics through hormones. What is the relation between andropause and well-known geriatric syndromes? 2013;74(3):213–219.
  6. Sites CK. Bioidentical hormones for menopausal therapy. Womens Health (Lond Engl) 2008;4:163–171.
  7. Montplaisir J, Lorrain J, Denesle R, Petit D. Sleep in menopause: differential effects of two forms of hormone replacement therapy. 2001;8:10–16.
  8. Cirigliano M. Bioidentical hormone therapy: a review of the evidence. J Womens Health (Larchmt) 2007;16:600–631.
  9. MacLennan A, Lester S, Moore V. Oral oestrogen replacement therapy versus placebo for hot flushes. Cochrane Database Syst Rev. 2001;(1):CD002978.
  10. Cauley JA, Robbins J, Chen Z, et al. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women’s Health Initiative randomized trial. 2003;290:1729–1738.
  11. Rymer J, Morris EP. Extracts from “Clinical Evidence”: menopausal symptoms. 2000;321:1516–1519.
  12. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. 2002;288:321–333.
  13. Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. 2004;291:47–53.
  14. Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause Society. 2007;14:168–182.
  15. Ettinger B, Ensrud KE, Wallace R, et al. Effects of ultralow-dose transdermal estradiol on bone mineral density: a randomized clinical trial. Obstet Gynecol. 2004;104:443–451.
  16. Schunkert H, Danser AH, Hense HW, Derkx FH, Kurzinger S, Riegger GA. Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. 1997;95:39–45.
  17. Blumel JE, Castelo-Branco C, Leal T, et al. Effects of transdermal estrogens on endothelial function in postmenopausal women with coronary disease. 2003;6:38–44.
  18. Le Gal G, Gourlet V, Hogrel P, Plu-Bureau G, Touboul PJ, Scarabin PY. Hormone replacement therapy use is associated with a lower occurrence of carotid atherosclerotic plaques but not with intima-media thickness progression among postmenopausal women. The vascular aging (EVA) study. 2003;166:163–170.
  19. Opatrny L, Dell’Aniello S, Assouline S, Suissa S. Hormone replacement therapy use and variations in the risk of breast cancer. 2008;115:169–175. discussion 75.
  20. Lippert C, Seeger H, Mueck AO. The effect of endogenous estradiol metabolites on the proliferation of human breast cancer cells. Life Sci. 2003;72:877–883.
  21. Mueck AO, Seeger H. Breast cancer: are estrogen metabolites carcinogenic? 2007;10(Suppl. 2):62–65.
  22. Lyytinen H, Pukkala E, Ylikorkala O. Breast cancer risk in postmenopausal women using estrogen-only therapy. Obstet Gynecol. 2006;108:1354–1360.
  23. Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat. 2008;107:103–111.
  24. Kuiper GG, Carlsson B, Grandien K, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. 1997;138:863–870.
  25. Weiderpass E, Baron JA, Adami HO, et al. Low-potency oestrogen and risk of endometrial cancer: a case-control study. 1999;353:1824–1828.
  26. Rosenberg LU, Magnusson C, Lindstrom E, Wedren S, Hall P, Dickman PW. Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study. Breast Cancer Res. 2006;8:R11.
  27. Iosif CS. Effects of protracted administration of estriol on the lower genito urinary tract in postmenopausal women. Arch Gynecol Obstet. 1992;251:115–120.
  28. Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med. 1993;329:753–756.
  29. Yang TS, Tsan SH, Chang SP, Ng HT. Efficacy and safety of estriol replacement therapy for climacteric women. Zhonghua Yi Xue Za Zhi (Taipei) 1995;55:386–391
  30. Moskowitz D. A comprehensive review of the safety and efficacy of bioidentical hormones for the management of menopause and related health risks. Altern Med Rev. 2006;11:208–223.
  31. Sitruk-Ware R. Pharmacological profile of progestins. 2004;47:277–283.
  32. Sitruk-Ware R. Progestogens in hormonal replacement therapy: new molecules, risks, and benefits. 2002;9:6–15.
  33. Schmidt IU, Wakley GK, Turner RT. Effects of estrogen and progesterone on tibia histomorphometry in growing rats. Calcif Tissue Int. 2000;67:47–52.
  34. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. 1995;273:199–208.
  35. Fournier A, Berrino F, Riboli E, Avenel V, Clavel-Chapelon F. Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort. Int J Cancer. 2005;114:448–454.
  36. Wren BG, Champion SM, Willetts K, Manga RZ, Eden JA. Transdermal progesterone and its effect on vasomotor symptoms, blood lipid levels, bone metabolic markers, moods, and quality of life for postmenopausal women. 2003;10:13–18.
  37. Wren BG, McFarland K, Edwards L, et al. Effect of sequential transdermal progesterone cream on endometrium, bleeding pattern, and plasma progesterone and salivary progesterone levels in postmenopausal women. 2000;3:155–160.
  38. Panjari M, Davis SR. DHEA therapy for women: effect on sexual function and wellbeing. Hum Reprod Update. 2007;13:239–248.
  39. Genazzani AD, Lanzoni C, Genazzani AR. Might DHEA be considered a beneficial replacement therapy in the elderly? Drugs Aging. 2007;24:173–185.
  40. Hyde Z, Flicker L, Almeida OP, et al. Low free testosterone predicts frailty in older men: the health in men study. J Clin Endocrinol Metab. 2010;95:3165–3172.
  41. Dunn JF, Nisula BC, Rodbard D. Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab. 1981;53:58–68.
  42. Pardridge WM. Serum bioavailability of sex steroid hormones. Clin Endocrinol Metab. 1986;15:259–278.
  43. Leifke E, Gorenoi V, Wichers C, Von Zur Muhlen A, Von Buren E, Brabant G. Age-related changes of serum sex hormones, insulin-like growth factor-1 and sex-hormone binding globulin levels in men: cross-sectional data from a healthy male cohort. Clin Endocrinol (Oxf) 2000;53:689–695.
  44. Morley JE, Kim MJ, Haren MT. Frailty and hormones. Rev Endocr Metab Disord. 2005;6:101–108.
  45. Wu FC, Tajar A, Pye SR, et al. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab. 2008;93:2737–2745.
  46. Lapauw B, Goemaere S, Zmierczak H, et al. The decline of serum testosterone levels in community-dwelling men over 70 years of age: descriptive data and predictors of longitudinal changes. Eur J Endocrinol. 2008;159:459–468.
  47. Sattler FR, Castaneda-Sceppa C, Binder EF, et al. Testosterone and growth hormone improve body composition and muscle performance in older men. , J Clin Endocrinol Metab. 2009 Jun;94(6):1991-200.


Scroll to Top


The 6 Keys to Reversing Pain, Embarrassment, and Discomfort.

Anti-Inflammatory & Digestion Enhancing Recipes.

Enjoy a Healthy Happy Tummy.